Carolinas Wealth Consulting’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
TWM
EFG
APA
FGA
PFA
Carolinas Wealth Consulting's BTAL Position: Q2 2023 in Review
Carolinas Wealth Consulting sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q2 2023, closing a stake of 477 shares — an estimated $9.73K sold.
Carolinas Wealth Consulting first reported a position in BTAL in Q1 2022 and held it in 3 quarters. The position peaked at $20K in Q3 2022. 72 funds tracked by Wall St. Rank hold BTAL as of Q2 2023.
- Carolinas Wealth Consulting reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q2 2023 after selling out during the quarter.
- Carolinas Wealth Consulting sold 477 AGF US Market Neutral Anti-Beta Fund shares in Q2 2023, an estimated $9.73K.
- Carolinas Wealth Consulting first reported a position in AGF US Market Neutral Anti-Beta Fund in Q1 2022 and held it in 3 quarters.
- Carolinas Wealth Consulting's AGF US Market Neutral Anti-Beta Fund position peaked at $20K in Q3 2022.
- 72 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2023.
Based on Carolinas Wealth Consulting's 13F filing for Q2 2023, filed 14 Aug 2023.